Veeva Systems VEEV
US equityMarket cap rank #488Health Information ServicesAI application softwareAI medical concept stocksSaaS
$266.22 +$3.30 (+1.26%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $266.61 +0.15%
Open$259.25
Prev close$262.92
Day range$259.25 – $268.96
Volume1.60M
Market cap$43.10B
P/E (TTM)43.6
Dividend yield–
Earnings
Average move on report day±8.8%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+19.7%
Worst reaction-14.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2027/Q2 | 26 Aug 2026 | After Market | ±9.8% | +15.20% | Bigger than priced |
| 2027/Q1 | 3 Jun 2026 | After Market | ±13.8% | -0.07% | Within range |
| 2026/Q4 | 4 Mar 2026 | After Market | ±11.0% | +4.02% | Within range |
| 2026/Q3 | 20 Nov 2025 | After Market | ±8.8% | -9.77% | Bigger than priced |
| 2026/Q2 | 27 Aug 2025 | After Market | ±10.5% | -7.24% | Within range |
| 2026/Q1 | 28 May 2025 | After Market | ±10.3% | +19.00% | Bigger than priced |
| 2025/Q4 | 5 Mar 2025 | After Market | ±10.7% | +7.37% | Within range |
| 2025/Q3 | 5 Dec 2024 | After Market | ±8.4% | +8.11% | Within range |
| 2025/Q2 | 28 Aug 2024 | After Market | ±9.2% | +8.86% | Within range |
| 2025/Q1 | 30 May 2024 | After Market | ±9.0% | -10.27% | Bigger than priced |
| 2024/Q4 | 29 Feb 2024 | After Market | ±9.8% | -1.55% | Within range |
| 2024/Q3 | 6 Dec 2023 | After Market | ±8.6% | -3.05% | Within range |
| 2024/Q2 | 30 Aug 2023 | After Market | ±8.7% | +8.36% | Within range |
| 2024/Q1 | 31 May 2023 | After Market | ±9.7% | +19.67% | Bigger than priced |
| 2023/Q4 | 1 Mar 2023 | After Market | ±10.4% | +4.47% | Within range |
| 2023/Q2 | 31 Aug 2022 | After Market | ±9.5% | -14.00% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2027/Q2
By business line
Fundamentals
Latest reported quarter: Q2, ended Jul 2026
Revenue$927.96M+17.6% YoY
Operating profit$275.02M+40.4% YoY
Net profit$273.43M+36.5% YoY
Diluted EPS$1.66+39.5% YoY
Free cash flow$238.71M+0.1% YoY
Operating cash flow$238.71M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin75.0%
Operating margin29.9%
Net margin29.3%
Return on equity14.4%
Return on assets11.9%
Return on invested capital14.2%
Current ratio5.46
Liabilities / assets18.0%
Cash & investments$7.24B
Total debt$137.06M
Net cash (debt)$7.11B
Free cash flow / sales48.2%
No comments yet — be the first to weigh in on VEEV.
Sign in to join the discussion.